Search | Clinical Trials Finder

Independent directory Public ClinicalTrials.gov records United States

ClinicalTrials.gov public records Last synced Sep 23, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 24 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Intervention: LY333334 Clear all

Conditions: Postmenopausal Osteoporosis
Interventions: Romozosumab, Teriparatide; Drug
Lead sponsor: Amgen; Industry
Eligibility: 55 Years to 90 Years · Female only
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 5
States / cities: Gainesville, Georgia • Bethesda, Maryland • Boston, Massachusetts + 1 more

Conditions: Fractures
Interventions: Teriparatide, Placebo; Drug
Lead sponsor: Ohio Orthopedic Center of Excellence; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Upper Arlington, Ohio

Conditions: Implant
Interventions: Teriparatide, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 30 Years to 85 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Osteoporosis
Interventions: Teriparatide; Drug
Lead sponsor: Pfenex, Inc; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Evansville, Indiana

Conditions: Osteoporosis
Interventions: zoledronic acid; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: Up to 85 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Osteoporosis
Interventions: Teriparatide, Alendronate, Calcium, Vitamin D3; Drug · Dietary Supplement
Lead sponsor: Helen Hayes Hospital; Other
Eligibility: 45 Years to 85 Years · Female only
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2017
U.S. locations: 1
States / cities: West Haverstraw, New York

Conditions: Osteoporosis
Interventions: denosumab, teriparatide; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older · Female only
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis, Postmenopausal
Interventions: teriparatide, Placebo, Calcium Supplement, Vitamin D Supplement; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 30 Years to 85 Years · Female only
Enrollment: 1,637 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 1999
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis
Interventions: Teriparatide (PF708), Teriparatide (Forteo); Drug
Lead sponsor: Pfenex, Inc; Industry
Eligibility: 30 Years to 85 Years
Enrollment: 181 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 26
States / cities: Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 22 more

Conditions: Osteoporosis, Knee Osteoarthritis
Interventions: Not listed
Lead sponsor: Edward Fox; Other
Eligibility: 40 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Secondary Hyperparathyroidism
Interventions: Teriparatide; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 40 Years to 59 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoporosis
Interventions: Ronacaleret, Teriparatide, Alendronate; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 79 Years · Female only
Enrollment: 564 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 9
States / cities: Oakland, California • Palm Desert, California • Walnut Creek, California + 6 more

Conditions: Osteoporosis, Postmenopausal, Osteoporosis
Interventions: Romosozumab, Teriparatide; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis, Postmenopausal
Interventions: Abaloparatide, Teriparatide; Drug
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 50 Years and older · Female only
Enrollment: 22,054 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis
Interventions: teriparatide, Placebo, BA058 20 µg, BA058 40 µg, BA058 80 µg; Drug
Lead sponsor: Radius Health, Inc.; Industry
Eligibility: 55 Years to 85 Years · Female only
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Postmenopausal Osteoporosis
Interventions: Teriparatide 40-mcg subcutaneous injection, Denosumab Injection, Alendronate Oral Tablet; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older · Female only
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis, Atypical Femoral Fracture
Interventions: teriparatide; Drug
Lead sponsor: Susan L. Greenspan; Other
Eligibility: Female only
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoporosis
Interventions: FORTEO; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: Not listed
Enrollment: 4,167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Lakewood, Colorado

Conditions: Osteoporosis
Interventions: Teriparatide, Risedronate; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 45 Years to 120 Years · Female only
Enrollment: 12,757 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis
Interventions: Teriparatide, Risedronate, Placebo, Calcium, Vitamin D; Drug · Dietary Supplement
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 50 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 6
States / cities: Fort Lauderdale, Florida • New Port Richey, Florida • Orlando, Florida + 3 more

Conditions: Osteoporosis, Osteopenia
Interventions: Calcium carbonate, Calcium Phosphate; Drug
Lead sponsor: Creighton University; Other
Eligibility: 60 Years to 85 Years · Female only
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Hypoparathyroidism
Interventions: PTH; Drug
Lead sponsor: John P. Bilezikian; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Postmenopausal Osteoporosis
Interventions: Teriparatide, Denosumab; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 45 Years and older · Female only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bone Loss, Periodontitis
Interventions: Periodontal surgery, FORTEO, Placebo, Vitamin D and Calcium; Procedure · Drug · Dietary Supplement
Lead sponsor: University of Michigan; Other
Eligibility: 30 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Ann Arbor, Michigan